To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03292406
Title A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)
Acronym CTCL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Galderma R&D
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | DEU


No variant requirements are available.